India  

Maiden Pharma under scrutiny after 66 children died consuming cough syrup in Gambia

DNA Sunday, 9 October 2022
The drug regulators have obtained samples of cold and cough medicine from Maiden Pharmaceuticals in response to a WHO medical alert.
0
shares
ShareTweetSavePostSend
 
Video Credit: Oneindia - Published
News video: WHO: 4 Indian cough syrups being probed after 66 children die in Gambia|Oneindia news *International

WHO: 4 Indian cough syrups being probed after 66 children die in Gambia|Oneindia news *International 02:22

The World Health Organisation on Wednesday warned that four "contaminated" and "substandard" cough syrups, allegedly produced by Maiden Pharmaceuticals Limited based in Haryana's Sonipat could be the reason for the deaths of at least 66 children in The Gambia. This has brought at least 4 cough syrups...

You Might Like


Related videos from verified sources

Cough Syrup [Video]

Cough Syrup

In the Gambia, parents react to the recent measures taken by the authorities to stop the import of cough syrups that have been linked to the deaths of 69 children in the country. "If it is due..

Credit: Rumble     Duration: 04:28Published
Cough Syrup in Gambia [Video]

Cough Syrup in Gambia

In the Gambia, parents react to the recent measures taken by the authorities to stop the import of cough syrups that have been linked to the deaths of 69 children in the country. "If it is due..

Credit: Rumble     Duration: 04:28Published

Related news from verified sources

Haryana STOPS cough syrup production by Maiden Pharma linked to 66 child deaths in Gambia

Earlier on Monday, the Indian Pharma company had released a statement over the reports linking its cough syrups to the deaths of 66 children in Gambia.  
Zee News

Maiden Pharma may lose import-export licence over cough syrup controversy in Gambia

The suspension of membership implies that Maiden Pharmaceuticals will not be eligible to receive any incentives.
DNA

With raids and show-cause notice, govt plans mega crackdown on cough syrup maker under WHO lens over Gambia deaths

The WHO warned that four cough syrups produced by Maiden Pharmaceuticals Limited could be the reason for the deaths of 66 children in The Gambia.
DNA Also reported by •newKerala.com